Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cryoballoon vs. Rhythmia Guided Ablation for Recurrent Atrial Fibrillation Following Initial Cryoballoon Pulmonary Vein Isolation

NCT03811795 is registered in ClinicalTrials.gov with Valley Health System as lead sponsor.

NCT NCT03811795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03811795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cryoballoon vs. Rhythmia Guided Ablation for Recurrent Atrial Fibrillation Following Initial Cryoballoon Pulmonary Vein Isolation
Lead sponsor
Valley Health System
Phase
Not applicable
Overall status
Completed
Start date
November 27, 2018
Completion date
April 26, 2022
Enrollment
9 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation